Nadolol
NDC 68001-690, Nadolol, tablet, from BluePoint Laboratories.
- Product NDC
- 68001-690
- Status
- Listed
- Labeler
- BluePoint Laboratories
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA201893
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68001-690 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NADOLOL20 mg/1
Pharmacologic classes
Adrenergic beta-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68001-690-00 | 68001069000 | 100 TABLET in 1 BOTTLE (68001-690-00) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f11553f1-18ec-41b0-a7ad-1c9f21ef2c9fNADAC price for package 68001069000
GET /v1/drugs/nadac/68001069000
Use it
Look up 68001-690 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68001-690 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68001-690. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.